cyclosporine has been researched along with Germinoblastoma in 80 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.25) | 18.7374 |
| 1990's | 44 (55.00) | 18.2507 |
| 2000's | 25 (31.25) | 29.6817 |
| 2010's | 7 (8.75) | 24.3611 |
| 2020's | 3 (3.75) | 2.80 |
| Authors | Studies |
|---|---|
| García-Basas, L; Gómez de Salazar-López de Silanes, E; Herrera-Puente, P; Núñez-Torrón-Stock, C; Pueyo-López, C; Sánchez-Cuervo, M | 1 |
| Arber, D; Avigan, DE; Foss, FM; Gascoyne, RD; Hogan, WJ; Horning, SJ; Jegede, O; Lazarus, HM; Litzow, MR; Luger, SM; Miller, KB; Sprague, KA; Stadtmauer, EA; Strair, RK; Tallman, MS; Wagner, H; Wang, XV; Whiteside, TL | 1 |
| Abgueguen, P; Cottin, L; Daniel, V; Dieu, X; François, S; Giltat, A; Hunault, M; Lacombe, V; Nunes Gomes, C; Orvain, C; Riou, J; Robin, JB; Schmidt, A; Thépot, S; Ugo, V | 1 |
| Ishida, Y; Itokawa, T; Koyama, Y; Toyonaga, Y; Yamazaki, K | 1 |
| Barba, P; Bautista, G; Cabrera, JR; Duarte, R; Esquirol, A; Fores, R; García, I; García-Marco, JA; Heras, I; Marquez-Malaver, FJ; Martino, R; Parody, R; Regidor, C; Rovira, M; Saavedra, S; Sánchez-Ortega, I; Serrano, D; Sierra, J; Vazquez, L | 1 |
| Dehoedt, C; Jin, F; Li, F; Li, P; Rao, J; Wang, M; Yang, G; Yang, Y; Zhang, R; Zhou, Y | 1 |
| Daloglu, H; Dincer, Z; Karasu, G; Uygun, V; Yesilipek, MA | 1 |
| Beems, RB; de Vries, A; Luijten, M; Robinson, J; van Kesteren, PC; van Steeg, H | 1 |
| Bahador, A; Dehghani, M; Geramizadeh, B; Imanieh, MH; Lankarani, KB; Malek-Hosseini, SA; Nikeghbalian, S; Salahi, H; Sharifian, M | 1 |
| Baron, J; Lin, H; Penumalli, V; Rezania, K; Soliven, B; van Besien, K | 1 |
| Chen, Z; Garcia-Prieto, C; Hammoudi, N; Huang, P; Jin, Z; Kang, Y; Lou, C; Mei, Y; Riaz Ahmed, KB; Zhou, Y | 1 |
| Baron, F; Beguin, Y; Fillet, G | 1 |
| D'Costa, S; Hurwitz, JL; Slobod, KS | 1 |
| Bates, WD; Chetty, R; Dada, MA; Davies, DR; Gatter, KC; Gray, DW; Morris, PJ | 1 |
| Bartynski, WS; Lister, J; Shadduck, RK; Zeigler, ZR | 1 |
| Fernández-Abellán, P; Garcia Garay, MC; Palmero, MF; Rivas, C; Sánchez-González, B; Villarrubia, B | 1 |
| Hoyle, C; Kazmi, M; Radia, D; Schey, SA; Streetly, M | 1 |
| Blackwood, L; German, AJ; O'Neill, T; Stell, AJ | 1 |
| Parry, G; Rolland, SL; Seymour, RA; Thomason, JM; Wilkins, BS | 1 |
| Anasetti, C; Appelbaum, FR; Deeg, J; Ghetie, V; Gooley, T; Hansen, JA; Martin, PJ; Nash, RA; Pei, J; Petersdorf, EW; Schindler, J; Storb, R; Vitetta, ES | 1 |
| Bal, V; Butcher, GW; Cox, JH; Howard, JC; Ivanyi, J; Lamb, JR; Owen, MJ | 1 |
| Innocenti, F; Mani, S; Prado, M; Ramírez, J; Ratain, MJ; Schilsky, RL; Undevia, SD; Vogelzang, NJ | 1 |
| Dadlani, C; Orlow, SJ | 1 |
| Antonenas, V; Bradstock, KF; Gottlieb, DJ; Hertzberg, MS; Huang, G; Kerridge, IH; McGurgan, M; Svennilson, J | 1 |
| Barkholt, L; Bodegård, H; Böttiger, Y; Remberger, M; Ringdén, O | 1 |
| Bertz, H; Finke, J; Grüllich, C; Müller, CI; Spyridonidis, A | 1 |
| Pukkala, E; Ranki, A; Reitamo, S; Sarna, S; Väkevä, L | 1 |
| Beutner, KR; Bhushan, R; Elmets, CA; Feldman, SR; Gordon, KB; Gottlieb, A; Koo, JY; Korman, NJ; Lebwohl, M; Leonardi, CL; Menter, A; Van Voorhees, AS | 1 |
| Kamel, OW; van de Rijn, M | 1 |
| McCaffrey, PG; Rao, A; Wang, DZ | 1 |
| Dagis, AC; Molina, A; Nademanee, A; O'Donnell, M; Parker, P; Schmidt, GM; Smith, EP; Snyder, DS; Stein, A; Stepan, DE | 1 |
| Bellamy, J; Benoit, G; Blanchet, P; Charpentier, B; Hiesse, C; Kriaa, F; Larue, JR | 1 |
| Ballardie, FW; Chalmers, RJ; Edwards, BD; Morris, DJ; O'Driscoll, JB | 1 |
| Gotti, E; Remuzzi, G | 1 |
| Boyer, M; Cointault, O; Durand, D; Fournial, G; Huyn, A; Lloveras, JJ; Rostaing, L; Suc, JM | 1 |
| Louahed, J; Renauld, JC; Van Snick, J; Vink, A | 1 |
| Penn, I | 2 |
| Dunn, DL; Gillingham, K; Gruber, SA; Matas, AJ; Sothern, RB; Stephanian, E | 1 |
| Elmhorn-Rosenborg, A; Juliusson, G; Paul, C; Peterson, C; Tidefelt, U | 1 |
| Chen, CS; Chen, HW; Chu, SH; Chuang, CK; Huang, CC; Lai, MK | 1 |
| Chavers, B; Dunn, DL; Gillingham, K; Gruber, SA; Matas, AJ; Sothern, RB; Stephanian, E | 1 |
| Kennedy, MJ | 1 |
| Barry, JM; Batiuk, TD; Bennett, WM; Meyer, MM; Norman, DJ; Tolzman, D | 1 |
| Present, DH | 1 |
| Benalia, H; Bitker, MO; Chartier-Kastler, E; Chatelain, C; Jacobs, C; Luciani, J; Mouquet, C; Ourhama, S; Viars, P | 1 |
| Griesmacher, A; Grimm, M; Klepetko, W; Müller, MM; Vogl, M | 1 |
| Siegel, JN; Taylor-Fishwick, DA | 1 |
| Cox, DC; Steele, TA | 2 |
| Asfar, S; Garcia, B; Gelb, A; Grant, D; Sharpe, M; Stiller, C; Tucker, J; Wall, W; Zhang, Z; Zhong, R | 1 |
| Amato-Neto, V; Bacal, F; Bellotti, G; Bocchi, EA; Fiorelli, A; Higuchi, ML; Jatene, AD; Mocelin, AO; Pileggi, F; Stolf, NA; Uip, D | 1 |
| Bacigalupo, A; Brinch, L; Cook, G; Domingo-Albos, A; Finke, J; Garcia-Conde, J; Gratwohl, A; Labopin, M; Lambertenghi-Deliliers, G; Lange, A; Laporte, JP; Majolino, I; Rozman, C; Schmitz, N | 1 |
| Amari, M; Amemiya, H; Chiba, K; Enosawa, S; Hoshino, Y; Kakefuda, T; Li, XK; Mitsusada, M; Naoe, S; Shinomiya, T; Suzuki, S; Takahara, S | 1 |
| Abhyankar, SH; Gee, AP; Godder, KT; Henslee-Downey, PJ; Pati, AR | 1 |
| Bagga, S; Gupta, SM; Johns, W | 1 |
| Bechstein, WO; Guckelberger, O; Jonas, S; Lobeck, H; Neuhaus, P; Neuhaus, R; Rayes, N; Riess, H; Schmidt, G; Tullius, SG; Vogl, T | 1 |
| Anhalt, GJ | 1 |
| Garzón, F; Madrid, A | 1 |
| Alfieri, C; Tanner, JE | 1 |
| Burke, GW; Byrne, GE; Ciancio, G; Cirocco, R; Esquenazi, V; Miller, J; Roth, D; Siquijor, AP | 1 |
| Gruessner, RW | 1 |
| Bechstein, WO; Guckelberger, O; Jonas, S; Neuhaus, P; Neuhaus, R; Neumann, U; Rayes, N; Serke, S; Tullius, SG | 1 |
| Miller, WT; Montone, KT; Siegel, SG | 1 |
| Hamano, S; Hirose, M; Hosoi, E; Kuroda, Y; Morimoto, M | 1 |
| Niaudet, P | 1 |
| Bartels, P; Buell, DN; Erdman, J; Fitzsimmons, WE; Hodosh, E; Horowitz, MM; Huang, C; Maher, R; Przepiorka, D; Wingard, JR; Zhang, MJ | 1 |
| Henderson, R; Prince, H | 1 |
| Byrne, JL; Carter, GI; Cull, GM; Hale, G; Haynes, AP; Miflin, G; Rebello, P; Russell, NH; Waldmann, H | 1 |
| Brugarolas, A; Calvo, JP; Gonzalez Manzano, R; Jimenez, MM; Lopez-Picazo, JM; Ordoñez Tres, JM | 1 |
| Evtodienko, Y; Kruglov, A; Kudrjavtsev, A; Odinokova, I; Teplova, V | 1 |
| Baron, F; Beguin, Y; Fillet, G; Gothot, A; Hermanne, JP; Pierard, GE; Salmon, JP | 1 |
| Brink, NS; Goldstone, AH; Kottaridis, PD; Linch, DC; Mackinnon, S; McKeag, N; Peggs, KS; Preiser, W; Tedder, RS | 1 |
| Durrant, S; Irving, I; Mollee, P; Morton, AJ | 1 |
| Antin, JH; Bierer, BE; Cowan, MJ; Ho, WG; Jiao, J; Kaizer, H; Lazarus, HM; Linker, C; Miller, KB; Petersen, FB; Petrarca, MA; Schiller, GJ; Small, T; Territo, MC; Tonetta, SA; Wingard, JR; Winston, DJ; Wolff, SN | 1 |
| Anasetti, C; Appelbaum, FR; Bowden, RA; Deeg, HJ; Doney, K; Longton, G; Nash, RA; Pepe, MS; Pettinger, M; Storb, R | 1 |
| Chu, SH; Chuang, CK; Huang, CC; Lai, MK | 1 |
| Feutren, G | 1 |
| Abboud, G; Epszteyn, S; Vitetta, ES; Yefenof, E | 1 |
| Lien, YH; Robinson, WA; Schröter, GP; Weil, R | 1 |
7 review(s) available for cyclosporine and Germinoblastoma
| Article | Year |
|---|---|
Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature.
Topics: 2-Chloroadenosine; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Deoxyadenosines; Fatal Outcome; Female; Humans; Lymphoma; Lymphoma, Follicular; Lymphoproliferative Disorders; Male; Middle Aged; Myasthenia Gravis; Paraneoplastic Syndromes, Nervous System; Prednisone; Pyridostigmine Bromide; Recurrence; Remission Induction; Rituximab; Waldenstrom Macroglobulinemia | 2012 |
Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
Topics: Adolescent; Age Factors; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Disease Susceptibility; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infections; Lymphoma; Male; Methotrexate; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Skin Diseases | 2005 |
Posttransplant malignancies in pediatric organ transplant recipients.
Topics: Adolescent; Adult; Age Factors; Child; Cyclosporine; Humans; Immunosuppression Therapy; Lymphoma; Neoplasms; Transplantation Immunology | 1994 |
Induced autologous graft-versus-host disease for the treatment of cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunotherapy; Interferon-gamma; Lymphoma; Mice; Neoplasms; Neoplasms, Experimental; Rats; Transplantation, Autologous | 1994 |
Paraneoplastic pemphigus.
Topics: Adult; Anti-Inflammatory Agents; Autoantigens; Autoimmune Diseases; Autoimmunity; Cell Adhesion Molecules; Cyclosporine; Drug Combinations; Epithelium; Humans; Immunosuppressive Agents; Lymphoma; Male; Middle Aged; Paraneoplastic Syndromes; Pemphigus; Prednisone | 1997 |
Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
Topics: Animals; B-Lymphocytes; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cocarcinogenesis; Cyclosporine; Gene Expression Regulation; Genes, Viral; Herpesviridae Infections; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunosuppressive Agents; Interleukin-6; Lymphocyte Subsets; Lymphoma; Lymphoproliferative Disorders; Mice; Mice, Nude; Monocytes; Neoplasm Proteins; Postoperative Complications; Transplantation; Tumor Virus Infections; Viral Proteins; Virus Activation | 1996 |
The optimal use of cyclosporin A in autoimmune diseases.
Topics: Autoimmune Diseases; Blood Pressure; Carcinoma, Squamous Cell; Cyclosporine; Dose-Response Relationship, Drug; Drug Monitoring; Humans; Kidney; Lymphoma | 1992 |
11 trial(s) available for cyclosporine and Germinoblastoma
| Article | Year |
|---|---|
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402 and 1902.
Topics: Adult; Allografts; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Pentostatin; Photopheresis; Tacrolimus; Transplantation Conditioning; Whole-Body Irradiation | 2020 |
Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidation.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Graft vs Host Reaction; Hodgkin Disease; Humans; Immunologic Factors; Interferon-alpha; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pilot Projects; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Treatment Outcome | 2004 |
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Topics: Adult; Antibodies, Monoclonal; Bone Marrow Transplantation; Cyclosporine; Female; Flow Cytometry; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunoconjugates; Intestines; Leukemia; Liver; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocyte Depletion; Lymphoma; Male; Middle Aged; Patient Selection; Receptors, Interleukin-2; Ricin; Skin; Survival Rate; T-Lymphocytes; Tissue Donors; Transplantation, Homologous | 2004 |
A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Area Under Curve; Camptothecin; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Endpoint Determination; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Half-Life; Humans; Hypnotics and Sedatives; Immunosuppressive Agents; Irinotecan; Lymphoma; Male; Middle Aged; Neoplasms; Phenobarbital | 2004 |
A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Vidarabine | 2008 |
Incidence and type of cancer following the use of OKT3: a single center experience with 557 organ transplants.
Topics: Adenoma, Bile Duct; Age Factors; Azathioprine; Cyclosporine; Follow-Up Studies; Humans; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lymphoma; Male; Muromonab-CD3; Neoplasms; Prostatic Neoplasms; Retrospective Studies; Skin Neoplasms; Thyroid Neoplasms | 1993 |
Influence of antilymphocyte globulin upon the incidence of malignancies after kidney transplantation.
Topics: Adult; Age Factors; Antilymphocyte Serum; Azathioprine; Cyclosporine; Follow-Up Studies; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Lymphoma; Middle Aged; Retrospective Studies; Time Factors | 1993 |
Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Bone Marrow Transplantation; Case-Control Studies; Cyclosporine; Diabetes Mellitus; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Gastrointestinal Diseases; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Kidney Diseases; Kidney Transplantation; Lymphoma; Male; Muromonab-CD3; Mycophenolic Acid; Nervous System Diseases; Pancreas Transplantation; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Survival Rate; Tacrolimus; Transplantation, Homologous | 1997 |
De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Clinical Trials as Topic; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphoma; Neoplasms, Second Primary; Prospective Studies; Randomized Controlled Trials as Topic; Receptors, Interleukin-2; Skin Neoplasms; Tacrolimus; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 1997 |
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Case-Control Studies; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Prospective Studies; Survival; Tacrolimus | 1999 |
A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anemia, Aplastic; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Graft vs Host Disease; Histocompatibility Testing; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Infections; Leukemia; Lymphocyte Depletion; Lymphoma; Male; Methotrexate; Middle Aged; Survival Analysis; Time Factors; Tissue Donors; Transplantation, Homologous | 2001 |
62 other study(ies) available for cyclosporine and Germinoblastoma
| Article | Year |
|---|---|
Evaluation of adherence and clinical outcomes in patients undergoing allogeneic haematopoietic stem cell transplantation.
Topics: Adult; Anti-Infective Agents; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Patient Compliance; Retrospective Studies; Treatment Outcome | 2020 |
Risk of infection according to the gamma globulin level in the 100 days following allogeneic stem cell transplantations.
Topics: Aged; Bacterial Infections; Cyclosporine; Female; gamma-Globulins; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Mycophenolic Acid; Mycoses; Myeloablative Agonists; Myelodysplastic Syndromes; Opportunistic Infections; Prognosis; ROC Curve; Transplantation Conditioning; Transplantation, Homologous; Virus Activation | 2021 |
Primary effusion lymphoma-like lymphoma unrelated to human herpesvirus 8 with aggressive clinical course in patient receiving cyclosporine.
Topics: Aged; Behcet Syndrome; Cyclosporine; Epstein-Barr Virus Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma; Lymphoma, Primary Effusion; Male; Neoplasm Recurrence, Local | 2013 |
Severe infections after single umbilical cord blood transplantation in adults with or without the co-infusion of CD34+ cells from a third-party donor: results of a multicenter study from the Grupo Español de Trasplante Hematopoyético (GETH).
Topics: Adolescent; Adult; Antigens, CD34; Bacterial Infections; Busulfan; Cohort Studies; Cord Blood Stem Cell Transplantation; Cyclosporine; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Multivariate Analysis; Mycoses; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Risk Factors; Severity of Illness Index; Thiotepa; Transplantation Conditioning; Vidarabine; Virus Diseases; Whole-Body Irradiation; Young Adult | 2015 |
Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; China; Cyclosporine; Etoposide; Female; Glucocorticoids; Health Knowledge, Attitudes, Practice; Herpesvirus 4, Human; Humans; Lymphohistiocytosis, Hemophagocytic; Lymphoma; Male; Middle Aged; Retrospective Studies; Young Adult | 2015 |
Haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide in high-risk children: A single-center study.
Topics: Adolescent; Blood Platelets; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Lymphoma; Male; Methylprednisolone; Mycophenolic Acid; Neutrophils; Retrospective Studies; Risk; Sepsis; Tacrolimus; Tissue Donors; Transplantation Conditioning | 2016 |
DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?
Topics: Adenocarcinoma; Animals; Biological Assay; Carcinogens; Cyclosporine; DNA Damage; Female; Lymphoma; Male; Mammary Neoplasms, Animal; Mice; Mice, Knockout; Mutagenicity Tests; Mutation; Precancerous Conditions; Tumor Suppressor Protein p53; Xeroderma Pigmentosum Group A Protein | 2009 |
Post-transplantation lymphoproliferative disorder after liver transplantation: report of 5 cases among more than 550 liver transplants in Iran.
Topics: Adolescent; Adult; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Child, Preschool; Cyclophosphamide; Cyclosporine; Fatal Outcome; Female; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Iran; Liver Transplantation; Lymphoma; Male; Mycophenolic Acid; Prednisolone; Tacrolimus; Vincristine | 2010 |
Effective killing of leukemia cells by the natural product OSW-1 through disruption of cellular calcium homeostasis.
Topics: Biological Products; Calcium; Calcium Channels; Calpain; Caspase 3; Cell Death; Cell Line, Tumor; Cholestenones; Cyclosporine; Cytochromes c; Cytosol; Drug Screening Assays, Antitumor; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme Activation; Extracellular Space; Heat-Shock Proteins; Homeostasis; Humans; Leukemia; Lymphoma; Membrane Potential, Mitochondrial; Mitochondria; Saponins; Sodium-Calcium Exchanger; Thapsigargin; Time Factors | 2013 |
Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation.
Topics: Adult; Cyclosporine; Erythropoiesis; Erythropoietin; Female; Graft Rejection; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Mycophenolic Acid; Receptors, Transferrin; Recombinant Proteins; Transplantation Conditioning; Transplantation, Homologous | 2002 |
Do the immunosuppressive drugs used as treatment for graft-versus-host disease directly inhibit lymphoid tumor cell growth?
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma; Mice; Mice, SCID; Prednisone; Tumor Cells, Cultured | 2003 |
Lymphoproliferative disorders in Oxford renal transplant recipients.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lymphoma; Male; Middle Aged; Postoperative Period; Prospective Studies; Registries; Treatment Outcome | 2003 |
Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation.
Topics: Adolescent; Adult; Aged; Bone Marrow Transplantation; Cerebral Cortex; Cyclosporine; Female; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged; Myelodysplastic Syndromes; Neurotoxicity Syndromes; Retrospective Studies; Survival Rate; Tacrolimus; Tomography, X-Ray Computed; Transplantation Conditioning; Whole-Body Irradiation | 2004 |
Rituximab and autologous stem cell transplantation for malignant lymphoma after liver transplantation.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Cyclosporine; Female; Humans; Immunohistochemistry; Liver Transplantation; Lymphoma; Prognosis; Remission Induction; Rituximab; Stem Cell Transplantation; Time Factors; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2004 |
Multicentric lymphoma in a dog after cyclosporine therapy.
Topics: Animals; Antifungal Agents; Anus Diseases; Blood Cell Count; Blood Chemical Analysis; Cyclosporine; Diagnosis, Differential; Dog Diseases; Dogs; Furunculosis; Immunosuppressive Agents; Ketoconazole; Lymphoma; Male | 2004 |
Post-transplant lymphoproliferative disorders presenting as gingival overgrowth in patients immunosuppressed with ciclosporin. A report of two cases.
Topics: Cyclosporine; Diagnosis, Differential; Gingival Neoplasms; Gingival Overgrowth; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphoma; Male; Middle Aged | 2004 |
The phenotypic and molecular characterization of Nb2 lymphoma cells activated with IL-2 and human growth hormone.
Topics: Animals; Blotting, Northern; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Drug Synergism; Human Growth Hormone; Humans; Immunoblotting; Immunophenotyping; Immunosuppressive Agents; Interleukin-2; Interleukin-4; Lymphocyte Activation; Lymphoma; Rats; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Interleukin-2; Recombinant Proteins; RNA, Messenger; T-Lymphocytes | 1989 |
Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
Topics: Adult; Antiviral Agents; Cord Blood Stem Cell Transplantation; Cyclosporine; Disease-Free Survival; Feasibility Studies; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia; Lymphoma; Male; Middle Aged; Pancytopenia; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2006 |
Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Child; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kinetics; Leukemia; Lymphoma; Male; Middle Aged; Neoplasms; Transplantation, Homologous | 2007 |
Long-term follow-up of cancer risk in patients treated with short-term cyclosporine.
Topics: Adolescent; Adult; Aged; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lymphoma; Male; Middle Aged; Risk Factors; Skin Diseases; Skin Neoplasms | 2008 |
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
Topics: Acitretin; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Biological Products; Cardiovascular Diseases; Cyclosporine; Depression; Etanercept; Humans; Immunoglobulin G; Interleukin-12; Interleukin-23; Lymphoma; Metabolic Syndrome; Methotrexate; Obesity; Psoriasis; PUVA Therapy; Receptors, Tumor Necrosis Factor; Recombinant Fusion Proteins; Smoking; Tumor Necrosis Factor-alpha | 2008 |
Cyclosporine and methotrexate for severe rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lymphoma; Methotrexate | 1995 |
The cyclosporin-sensitive transcription factor NFATp is expressed in several classes of cells in the immune system.
Topics: Amino Acid Sequence; Animals; Antibodies; B-Lymphocytes; Blotting, Western; Cell Line; Cells, Cultured; Cyclosporine; DNA-Binding Proteins; Electrophoresis, Polyacrylamide Gel; Gene Expression; Humans; Immune System; Lymphoma; Macrophages; Mice; Mice, Inbred BALB C; Molecular Sequence Data; NFATC Transcription Factors; Nuclear Proteins; Organ Specificity; Peptides; T-Lymphocytes; Transcription Factors; Tumor Cells, Cultured | 1995 |
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft Survival; Graft vs Host Disease; Histocompatibility; Humans; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Prednisone; Survival Analysis | 1995 |
Incidence and type of malignancies occurring after renal transplantation in conventionally and in cyclosporine-treated recipients: single-center analysis of a 20-year period in 1600 patients.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Leukemia; Lymphoma; Male; Melanoma; Neoplasms; Risk Factors; Skin Neoplasms; Time Factors | 1995 |
Should atypical lymphocytes and plasma cells in well patients with psoriasis on cyclosporin cause concern?
Topics: Cyclosporine; Cytomegalovirus; Herpesvirus 4, Human; Humans; Lymphocytes; Lymphoma; Plasma Cells; Psoriasis; Risk Factors; Virus Activation | 1993 |
Clinical problem solving. The girl with the curl.
Topics: Acyclovir; Antitubercular Agents; Cyclosporine; Female; Fever; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Kidney Transplantation; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphoma; Middle Aged; Prednisone | 1995 |
Decreased incidence of lymphomas after heart transplantation under low-dose immunosuppression.
Topics: Adult; Antilymphocyte Serum; Azathioprine; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Incidence; Lymphoma; Male; Methylprednisolone; Middle Aged | 1995 |
Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas.
Topics: Alkaloids; Animals; Apoptosis; Cell Division; Cyclosporine; Dexamethasone; DNA Damage; DNA, Neoplasm; Interleukin-2; Interleukin-4; Interleukin-7; Interleukin-9; Lymphoma; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Inbred DBA; Neoplasms, Radiation-Induced; Protein Kinase C; Signal Transduction; Staurosporine; Thymus Neoplasms; Tumor Cells, Cultured | 1995 |
De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Kidney Transplantation; Life Tables; Lymphoma; Male; Middle Aged; Neoplasms; Proportional Hazards Models; Risk Factors; Skin Neoplasms; Time Factors | 1994 |
Increased intracellular concentrations of doxorubicin in resistant lymphoma cells in vivo by concomitant therapy with verapamil and cyclosporin A.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Doxorubicin; Drug Interactions; Drug Resistance; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Male; Verapamil | 1994 |
Prognosis of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisolone.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Survival; Humans; Immunosuppression Therapy; Incidence; Kidney Transplantation; Lymphoma; Male; Middle Aged; Prednisolone; Retrospective Studies; Sex Factors; Treatment Outcome | 1994 |
Cancer development in pediatric primary renal allograft recipients.
Topics: Adolescent; Adult; Age Factors; Child; Cyclosporine; Female; Humans; Immunosuppression Therapy; Kidney Transplantation; Lymphoma; Male; Minnesota; Neoplasms; Skin Neoplasms | 1994 |
Cyclosporine and other immunosuppressive agents: current and future role in the treatment of inflammatory bowel disease.
Topics: Azathioprine; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Humans; Immunosuppressive Agents; Intestinal Neoplasms; Lymphoma; Mercaptopurine; Risk Factors | 1993 |
Tissue polypeptide specific antigen for the detection of lymphoproliferative diseases induced by cyclosporin.
Topics: Adult; Biomarkers, Tumor; Cyclosporine; Female; Follow-Up Studies; Heart Transplantation; Humans; Immunocompromised Host; Lung Transplantation; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Peptides; Postoperative Complications; Retrospective Studies | 1995 |
Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells.
Topics: Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cyclosporine; Dose-Response Relationship, Immunologic; Down-Regulation; Humans; Immunosuppressive Agents; Ionomycin; Ionophores; Lectins, C-Type; Lymphoma; Mitogens; Protein Serine-Threonine Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Up-Regulation | 1995 |
Reovirus type 3 chemoimmunotherapy of murine lymphoma is abrogated by cyclosporine.
Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; Combined Modality Therapy; Cyclosporine; Immunity, Innate; Immunosuppressive Agents; Immunotherapy; Killer Cells, Natural; Kinetics; Leukemia L1210; Lymphoma; Male; Mammalian orthoreovirus 3; Mice; Mice, Inbred Strains; Survival Rate; Tumor Cells, Cultured | 1995 |
Elimination of EL-4 and L1210 murine tumors by 1,3-bis (2-chloroethyl)-1-nitrosourea requires an intact immune response.
Topics: Animals; Antineoplastic Agents, Alkylating; Carmustine; Cyclosporine; Immunosuppressive Agents; Leukemia L1210; Lymphoma; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA | 1996 |
Long-term survival and functional tolerance of baboon to monkey kidney and liver transplantation: a preliminary report.
Topics: Animals; Cyclophosphamide; Cyclosporine; Graft Rejection; Graft Survival; Haplorhini; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Lymphoma; Mycophenolic Acid; Papio; Polyenes; Sirolimus; Transplantation, Heterologous | 1996 |
Cancers in cyclosporine-treated vs azathioprine-treated patients.
Topics: Adult; Azathioprine; Child; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Neoplasms; Kidney Transplantation; Lip Neoplasms; Lymphoma; Neoplasms; Sarcoma, Kaposi; Skin Neoplasms; Transplantation Immunology; Uterine Cervical Neoplasms; Vulvar Neoplasms | 1996 |
Heart transplantation for chronic Chagas' heart disease.
Topics: Actuarial Analysis; Adolescent; Adult; Azathioprine; Cause of Death; Chagas Cardiomyopathy; Child; Cyclosporine; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Lymphoma; Male; Methylprednisolone; Middle Aged; Myocarditis; Parasitemia; Prednisone; Recurrence; Sarcoma, Kaposi; Survival Rate; Treatment Outcome | 1996 |
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
Topics: Adolescent; Adult; Blood Donors; Busulfan; Child; Child, Preschool; Cyclosporine; Erythropoietin; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Leukemia; Lymphoma; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Prednisolone; Whole-Body Irradiation | 1996 |
Induction of lymphocyte apoptosis and prolongation of allograft survival by FTY720.
Topics: Animals; Apoptosis; Cell Line; Creatinine; Cyclosporine; Dogs; Fingolimod Hydrochloride; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphocytes; Lymphoma; Male; Mice; Mice, Mutant Strains; Neoplasm Transplantation; Propylene Glycols; Sphingosine; Time Factors; Transplantation, Homologous; Tumor Cells, Cultured | 1996 |
Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma.
Topics: Adult; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Lymphoma; Male; Middle Aged; Transplantation, Autologous | 1996 |
Scintigraphic detection of a disseminated synovial lymphoma in a postrenal transplant patient.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Cyclosporine; Female; Gallium Radioisotopes; Humans; Immunosuppressive Agents; Joint Diseases; Kidney Transplantation; Knee Joint; Liver Neoplasms; Lymphoma; Neoplasm Staging; Prednisone; Radionuclide Imaging; Synovial Membrane | 1996 |
Posttransplant malignancy and newer immunosuppressive protocols after liver transplantation.
Topics: Carcinoma, Hepatocellular; Cyclosporine; Follow-Up Studies; Hepatitis B; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Lymphoma; Neoplasms; Postoperative Complications; Retrospective Studies; Tacrolimus; Time Factors | 1996 |
[Primary cerebral lymphoma: atypical image].
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Cyclosporine; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Middle Aged | 1996 |
Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era.
Topics: Adolescent; Adult; Antibody Formation; Cause of Death; Child; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Incidence; Kidney Transplantation; Lymphoma; Male; Mycophenolic Acid; Prodrugs; Renal Dialysis; Survival Rate; Tacrolimus | 1997 |
Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population.
Topics: Abdomen; Adolescent; Adult; Brain Diseases; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Lymphoma; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Muromonab-CD3; Radiography, Abdominal; Retrospective Studies; Survival Rate; Thoracic Diseases; Tomography, X-Ray Computed | 1997 |
Effect of MDR antagonists on the cidal activity of vincristine for cells expressing MDR-1 is superior to those expressing MRP.
Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporine; Dipyridamole; Drug Interactions; Drug Resistance, Multiple; Humans; Leukemia; Lymphoma; Multidrug Resistance-Associated Proteins; RNA, Messenger; Tumor Cells, Cultured; Verapamil; Vincristine | 1998 |
Postransplant lymphoproliferative disease following renal transplantation: a multicenter retrospective study of 41 cases observed between 1992 and 1996. French Speaking Transplantation Workshop.
Topics: Azathioprine; Cyclosporine; Drug Therapy, Combination; Humans; Immunophenotyping; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lymphoma; Lymphoproliferative Disorders; Postoperative Complications; Retrospective Studies; Survival Analysis | 1998 |
Choice of conditional models in bivariate survival.
Topics: Age Factors; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Likelihood Functions; Lymphoma; Models, Biological; Multicenter Studies as Topic; Sarcoma, Kaposi; Sex Factors; Survival Analysis; Time Factors | 2000 |
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin; Transplantation Conditioning; Transplantation, Homologous | 2000 |
Epoch-cyclosporin A induces high response rates in relapsed lymphomas.
Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Humans; Lymphoma; Male; Pilot Projects; Prednisone; Recurrence; Treatment Outcome; Vincristine | 2000 |
Suppression of mitochondrial permeability transition pore and induction of lymphoma P388 cell death by cyclosporin A.
Topics: Animals; Cell Cycle; Cell Death; Cell Membrane Structures; Cyclosporine; Immunosuppressive Agents; Intracellular Membranes; Lymphoma; Mice; Mitochondria; Permeability; Reactive Oxygen Species; Vitamin K | 2000 |
Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Breast Neoplasms; Chi-Square Distribution; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Graft vs Leukemia Effect; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; HLA-B Antigens; HLA-DR6 Antigen; Hodgkin Disease; Humans; Immunosuppressive Agents; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Prospective Studies; Transplantation, Autologous | 2000 |
Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
Topics: Acyclovir; Adolescent; Adult; Antifungal Agents; Antiviral Agents; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Fluconazole; Foscarnet; Humans; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Postoperative Period; Prospective Studies; Risk; Survival Rate; Time Factors; Tissue Donors; Transplantation, Homologous | 2000 |
Combination therapy with tacrolimus and anti-thymocyte globulin for the treatment of steroid-resistant acute graft-versus-host disease developing during cyclosporine prophylaxis.
Topics: Acute Disease; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Isoantibodies; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myelodysplastic Syndromes; Tacrolimus; Transplantation, Homologous | 2001 |
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Hematologic Diseases; Humans; Leukemia; Lymphoma; Male; Methotrexate; Multivariate Analysis; Retrospective Studies; Risk Factors; Sex Factors; Survival Analysis; Tissue Donors; Transplantation, Homologous; Whole-Body Irradiation | 1992 |
Lymphoma in cyclosporine-treated renal transplant recipients.
Topics: Adult; Cyclosporine; Female; Humans; Kidney Transplantation; Lymphoma; Male | 1992 |
Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin.
Topics: Animals; Cyclosporine; Gene Products, env; Immunotoxins; Interleukin-4; Lymphoma; Mice; Mice, Inbred C57BL; Preleukemia; Radiation Leukemia Virus; Survival Analysis; Thymus Gland; Thymus Neoplasms; Tumor Cells, Cultured | 1992 |
Complete remission and possible immune tolerance after multidrug combination chemotherapy for cyclosporine-related lymphoma in a renal transplant recipient with acute pancreatitis.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Female; Humans; Immune Tolerance; Kidney Transplantation; Lymphoma; Pancreatitis | 1991 |